STRATA Skin Sciences, Inc. (SSKN)

Market Cap	11.22M
Revenue (ttm)	33.56M
Net Income (ttm)	-10.09M
Shares Out	4.17M
EPS (ttm)	-2.65
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,257
Open	2.580
Previous Close	2.700
Day's Range	2.580 - 2.690
52-Week Range	2.510 - 5.900
Beta	1.33
Analysts	Strong Buy
Price Target	6.00 (+123.05%)
Earnings Date	Mar 27, 2025

About SSKN

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 28, 2005
• Employees: 99
• Stock Exchange: NASDAQ
• Ticker Symbol: SSKN
• Website: https://www.strataskinsciences.com

Financial Performance

In 2024, STRATA Skin Sciences's revenue was $33.56 million, an increase of 0.61% compared to the previous year's $33.36 million. Losses were -$10.09 million, -6.87% less than in 2023.

Analyst Forecast

According to one analyst, the rating for SSKN stock is "Strong Buy" and the 12-month stock price forecast is $6.0.

Price Target

$6.0

(123.05% upside)

Analyst Consensus: Strong Buy